All the Active Ingredient Drugs
Anti-Androgen. Enzalutamide 40 mg. FC caps 120 X 40 mg
160 mg enzalutamide (4 caps.) as a sgle daily dose.
tmt of adult men with high-risk non-metast. castration resist. prostate cancer (CRPC). – tmt. of adult men with metast. CRPC who are asymptom. or mildly symptom. after failure of androgen deprivation ther. in whom chemother. is not yet clinically indicated.- tmt. of adult men with metast. CRPC whose dis. has progressed on or after docetaxel ther. - tmt of adult men with metast. hormone-sensitive prostate cancer (mHSPC) in combin. with androgen deprivation ther.
As monother. or in combin. with androgen deprivation ther. for the tmt of adult men with high risk biochemical recurrent (BCR) non-metast. hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiother.
C/I: hypersens. Women who are or may become pregn.
Anti-Androgen. Enzalutamide 40 mg. FC Tabs. 112. Recomm. dose
is 160 mg (four 40 mg tabs.) as a single oral dly. dose. See lit.
Tmt. of adult men with high-risk non-metast. castrat.-resist. prostate cancer (CRPC).
Tmt. of adult men with metast. CRPC who are asymptomat.or mildly symptom. after failure of androgen depriv. ther. in whom chemother. is not yet clinic. indic..
Tmt. of adult men with metast. CRPC whose dis. has progr. on or after docetaxel ther.
Tmt. of pts. with metast. castration-sensit. prostate cancer (mCSPC).
